New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
09:13 EDTIDRAIdera Pharmaceuticals 6.84M share Spot Secondary priced at $4.00
Piper Jaffray and Cowen acted as joint book running managers for the offering.
News For IDRA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
11:03 EDTIDRAIdera Pharmaceuticals granted orphan status for lymphoma treatment
The FDA granted Idera Pharmaceuticals orphan status for its treatment of diffuse large B-cell lymphoma.
March 23, 2015
09:27 EDTIDRAIdera Pharmaceuticals Chief Medical Officer resigns
Idera Pharmaceuticals disclosed in a regulatory filing that Louis Brenner, M.D. resigned his positions as senior VP and Chief Medical Officer of Idera to accept a new role as the Chief Operating Officer of a privately-held biotechnology company. This change will become effective April 3.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use